FibroBiologics has engaged with Southern Star Research to provide clinical research organization services for FibroBiologics in Australia. Initial CRO services will include preparatory work for a Phase 1/2 clinical trial utilizing product candidate, CYWC628, to treat diabetic foot ulcers.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FBLG:
- FibroBiologics files patent application for fibroblast cell-based technology
- FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based Technology
- FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment Conference
- FibroBiologics initiated with a Buy at EF Hutton
- FibroBiologics Raises Funds Through Strategic Equity Sales to GEM
Questions or Comments about the article? Write to editor@tipranks.com